+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
G-Protein Coupled Receptors Market - Global Forecast 2025-2030- Product Image
G-Protein Coupled Receptors Market - Global Forecast 2025-2030- Product Image
Sale

G-Protein Coupled Receptors Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887241
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The G-Protein Coupled Receptors Market is evolving rapidly as innovation in structural biology and computational drug design converges with rising demand for novel therapeutics across multiple disease areas. Senior executives focused on growth and resilience are seizing new opportunities as GPCRs drive the next wave of biomedical advances.

Market Snapshot: G-Protein Coupled Receptors Market

In the latest analysis, the G-Protein Coupled Receptors market grew from USD 3.51 billion in 2024 to USD 3.74 billion in 2025. A strong compound annual growth rate of 6.30% is projected, with the market expected to reach USD 5.07 billion by 2030. This expansion reflects the growing importance of GPCRs in pharmaceutical pipelines, supported by ongoing scientific collaboration and increasing investment in emerging technologies and regional development.

Scope & Segmentation

  • Receptor Classes: Class A Rhodopsin, Class B Secretin, Class C Metabotropic Glutamate, Class F Frizzled/Taste 2, Orphan Receptors, including focus areas such as amino acid, chemokine, lipid, monoamine, opsin, and peptide receptors.
  • Therapeutic Areas: Cardiovascular, CNS disorders, gastrointestinal and metabolic diseases, inflammation, oncology (breast, colorectal, leukemia, lung, prostate), pain management, respiratory disorders.
  • Applications: Drug discovery, clinical trials (Phase I, II, III), diagnostics, preclinical development.
  • End Users: Academic and research institutes, contract research organizations, diagnostic laboratories, pharmaceutical and biotech companies.
  • Regions Covered: Americas (including specific states and countries), Europe/Middle East/Africa (detailed key markets), Asia-Pacific (with major markets such as China, Japan, South Korea, and India).
  • Key Companies Profiled: F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co., Inc., Johnson & Johnson, AstraZeneca PLC, Sanofi S.A., Bristol-Myers Squibb Company, GlaxoSmithKline plc, AbbVie Inc.

Key Takeaways for Senior Decision-Makers

  • GPCRs remain at the forefront of drug development, with continued diversification across class types and therapeutic uses, broadening commercial avenues for biopharma stakeholders.
  • Technological advancements in cryo-electron microscopy and machine learning are accelerating the identification and validation of receptor targets, reducing time to clinical decision points.
  • Biased agonism and allosteric modulation strategies are unlocking new avenues for therapeutic selectivity and minimizing off-target side effects in development portfolios.
  • Regional research capability and funding variations are creating nuanced market entry points, with collaborative networks in North America, Europe, and Asia-Pacific contributing to innovation and speed to market.
  • Dynamic partnerships, particularly among leading pharmaceutical, biotechnology, and academic research teams, are enhancing data integration, translational research, and access to specialized patient groups.

Tariff Impact on GPCR Supply Chains

Recent United States tariff policies have increased costs and procurement complexity for key reagents, assay kits, and analytical equipment in the GPCR field. Supply chain strategies now include greater regional diversification, increased domestic sourcing, and strengthened alliances with niche providers. These adaptive measures are enabling organizations to ensure research continuity and cost management despite the new regulatory environment. Contract research organizations in the United States have also experienced increased demand for localized services as companies seek to mitigate global supply risk and pricing volatility.

Methodology & Data Sources

The market analysis integrates primary interviews with R&D executives and regulatory experts, supplemented by expert panel workshops. These insights are validated using secondary data sources such as peer-reviewed literature, public filings, clinical trial registries, and proprietary databases, supported by systematic analytics such as SWOT and PESTEL frameworks.

Why This Report Matters

  • Enables strategic resource allocation across multiple therapeutic and technology focus areas.
  • Equips leadership with actionable insights for supply chain optimization and risk mitigation in evolving market and regulatory conditions.
  • Facilitates data-driven partnership decisions, supporting sustained innovation and competitive positioning throughout the GPCR landscape.

Conclusion

This report offers a comprehensive overview of G-Protein Coupled Receptors market dynamics, presenting the trends, challenges, and collaborative opportunities shaping future growth. Senior leaders can leverage these insights to drive sustainable innovation and informed investment decisions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in cryo-EM guided structure-based drug design for GPCR targets
5.2. Emergence of biased agonists to selectively modulate GPCR signaling pathways
5.3. Identification and therapeutic exploration of orphan GPCR deorphanization efforts
5.4. Development of GPCR-targeted antibody therapies for enhanced specificity and efficacy
5.5. Application of artificial intelligence and machine learning to GPCR ligand discovery
5.6. Progress in allosteric modulator design to fine-tune GPCR receptor conformations
5.7. Exploitation of GPCR heteromerization for novel drug targeting and pathway biasing
5.8. Integration of photopharmacology approaches to achieve spatiotemporal control of GPCR activity
5.9. Advances in GPCR-targeted drug delivery using nanocarriers for tissue-specific engagement
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. G-Protein Coupled Receptors Market, by Receptor Class
8.1. Introduction
8.2. Class A Rhodopsin
8.2.1. Amino Acid Receptors
8.2.2. Chemokine Receptors
8.2.3. Lipid Receptors
8.2.4. Monoamine Receptors
8.2.5. Opsin Receptors
8.2.6. Peptide Receptors
8.3. Class B Secretin
8.4. Class C Metabotropic Glutamate
8.5. Class F Frizzled/Taste 2
8.6. Orphan Receptors
9. G-Protein Coupled Receptors Market, by Therapeutic Area
9.1. Introduction
9.2. Cardiovascular Diseases
9.3. Cns Disorders
9.4. Gastrointestinal Disorders
9.5. Inflammation
9.6. Metabolic Disorders
9.7. Oncology
9.7.1. Breast Cancer
9.7.2. Colorectal Cancer
9.7.3. Leukemia
9.7.4. Lung Cancer
9.7.5. Prostate Cancer
9.8. Pain Management
9.9. Respiratory Disorders
10. G-Protein Coupled Receptors Market, by Application
10.1. Introduction
10.2. Clinical Trials
10.2.1. Phase I
10.2.2. Phase II
10.2.3. Phase III
10.3. Diagnostics
10.4. Drug Discovery
10.5. Preclinical Development
11. G-Protein Coupled Receptors Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Contract Research Organizations
11.4. Diagnostic Laboratories
11.5. Pharmaceutical And Biotech Companies
12. Americas G-Protein Coupled Receptors Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa G-Protein Coupled Receptors Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific G-Protein Coupled Receptors Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. F. Hoffmann-La Roche Ltd.
15.3.2. Novartis AG
15.3.3. Pfizer Inc.
15.3.4. Merck & Co., Inc.
15.3.5. Johnson & Johnson
15.3.6. AstraZeneca PLC
15.3.7. Sanofi S.A.
15.3.8. Bristol-Myers Squibb Company
15.3.9. GlaxoSmithKline plc
15.3.10. AbbVie Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. G-PROTEIN COUPLED RECEPTORS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 8. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. G-PROTEIN COUPLED RECEPTORS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. G-PROTEIN COUPLED RECEPTORS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. G-PROTEIN COUPLED RECEPTORS MARKET: RESEARCHAI
FIGURE 24. G-PROTEIN COUPLED RECEPTORS MARKET: RESEARCHSTATISTICS
FIGURE 25. G-PROTEIN COUPLED RECEPTORS MARKET: RESEARCHCONTACTS
FIGURE 26. G-PROTEIN COUPLED RECEPTORS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. G-PROTEIN COUPLED RECEPTORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY AMINO ACID RECEPTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY AMINO ACID RECEPTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CHEMOKINE RECEPTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CHEMOKINE RECEPTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LIPID RECEPTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LIPID RECEPTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY MONOAMINE RECEPTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY MONOAMINE RECEPTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY OPSIN RECEPTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY OPSIN RECEPTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PEPTIDE RECEPTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PEPTIDE RECEPTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS B SECRETIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS B SECRETIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS C METABOTROPIC GLUTAMATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS C METABOTROPIC GLUTAMATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS F FRIZZLED/TASTE 2, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS F FRIZZLED/TASTE 2, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ORPHAN RECEPTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ORPHAN RECEPTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CNS DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CNS DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY INFLAMMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY INFLAMMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 125. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2024 (USD MILLION)
TABLE 126. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2025-2030 (USD MILLION)
TABLE 127. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2024 (USD MILLION)
TABLE 128. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2025-2030 (USD MILLION)
TABLE 129. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 130. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 131. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 132. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 133. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 136. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 137. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2024 (USD MILLION)
TABLE 140. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2025-2030 (USD MILLION)
TABLE 141. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2024 (USD MILLION)
TABLE 142. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2025-2030 (USD MILLION)
TABLE 143. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 144. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 145. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 146. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 147. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 151. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2025-2030 (USD MILLION)
TABLE 213. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2024 (USD MILLION)
TABLE 214. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2025-2030 (USD MILLION)
TABLE 215. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 216. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 217. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 218. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 219. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 222. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 223. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2024 (USD MILLION)
TABLE 226. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2025-2030 (USD MILLION)
TABLE 227. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2024 (USD MILLION)
TABLE 228. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2025-2030 (USD MILLION)
TABLE 229. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 230. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 231. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 232. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 233. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 236. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 237. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2024 (USD MILLION)
TABLE 254. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2025-2030 (USD MILLION)
TABLE 255. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2024 (USD MILLION)
TABLE 256. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2025-2030 (USD MILLION)
TABLE 257. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 258. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 259. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 260. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 261. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 264. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 265. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2024 (USD MILLION)
TABLE 268. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2025-2030 (USD MILLION)
TABLE 269. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2024 (USD MILLION)
TABLE 270. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2025-2030 (USD MILLION)
TABLE 271. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 272. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 273. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 274. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 275. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 278. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 279. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RECEPTOR CLASS, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLASS A RHODOPSIN, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CLINICAL TRIALS, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY END USER, 2025-2030 (USD MIL

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this G-Protein Coupled Receptors market report include:
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Johnson & Johnson
  • AstraZeneca PLC
  • Sanofi S.A.
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • AbbVie Inc.

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.74 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.07 Billion
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

G-Protein Coupled Receptors: Market Share, and Growth Analysis by Product Type (Small Molecule Drugs, Biologics), Application, End User, Technology - Product Image

G-Protein Coupled Receptors: Market Share, and Growth Analysis by Product Type (Small Molecule Drugs, Biologics), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
G-Protein Coupled Receptors Market Size, Share & Trends Analysis Report by Product (Cell Lines, Detection Kits), Application (Cancer Research, CNS Research), Assay, and Region with Growth Forecasts, 2025-2030 - Product Image

G-Protein Coupled Receptors Market Size, Share & Trends Analysis Report by Product (Cell Lines, Detection Kits), Application (Cancer Research, CNS Research), Assay, and Region with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
G-Protein Coupled Receptors Market 2025-2033 - Product Image

G-Protein Coupled Receptors Market 2025-2033

  • Report
  • 141 Pages
  • Global
From
G-Protein Coupled Receptors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

G-Protein Coupled Receptors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 184 Pages
  • Global
From
Global G-Protein Coupled Receptors (GPCR) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global G-Protein Coupled Receptors (GPCR) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 110 Pages
  • Global
From

About the G Protein Coupled Receptors Market

G Protein Coupled Receptors (GPCRs) are a class of proteins that are involved in a wide range of physiological processes, including cell signaling, metabolism, and homeostasis. They are the most abundant type of membrane receptor in the human body, and are involved in the regulation of many cellular processes. GPCRs are the target of many drugs, and are the focus of much research in the field of proteomics. Proteomics is the study of the structure and function of proteins, and GPCRs are a major focus of proteomics research. Proteomics research has enabled the development of new drugs and therapies that target GPCRs, and has also enabled the development of new diagnostic tools for diseases that involve GPCRs. Companies in the GPCR market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.